Health Canada
- Status: approved
🇨🇦 Belimumab plus Late Vaccination in Canada
Belimumab plus Late Vaccination (Belimumab plus Late Vaccination) regulatory status in Canada.
Marketing authorisation
Belimumab plus Late Vaccination in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Belimumab plus Late Vaccination approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Belimumab plus Late Vaccination in Canada?
Human Genome Sciences Inc., a GSK Company is the originator. The local marketing authorisation holder may differ — check the official source linked above.